Login / Signup

Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes.

K A ReynoldsD I SchlessingerA F YanesV Godinez-PuigB R ChenA O KurtaJ K CotseonesS G ChirenS IyengarSarah A IbrahimB Y KangB WorleyR BehshadD M DeHoratiusP DenesA M DruckerL M DzubowJ R EtzkornC A HarwoodJ Y S KimN LawrenceErica H LeeG S LissnerA A MarghoobA GuminiskiR N MatinA R MattoxB B MittalJ R ThomasX A ZhouD ZlotyB G M HughesM K NottageA C GreenA A E TestoriG ArgenzianoCaterina LongoI ZalaudekC LebbeJ MalvehyP SaiagS S CerneaJochen SchmittJ J KirkhamE PoonJ F SobankoT V CarteeI A MaherMurad Alam
Published in: The British journal of dermatology (2021)
In order to increase the comparability of results across trials and to reduce selective reporting bias, cSCC researchers should consider reporting these core outcomes. Further work needs to be performed to identify the measures that should be reported for each of these outcomes.
Keyphrases
  • squamous cell carcinoma
  • adverse drug
  • radiation therapy
  • lymph node metastasis
  • electronic health record
  • bioinformatics analysis